10-K: Green Planet Bioengineering Co., Ltd. Files 10-K Report for Fiscal Year 2023, Cites Going Concern Uncertainty
Annual Results
Green Planet Bioengineering Co., Ltd., a public reorganized shell corporation, reported its 2023 financial results, highlighting no operating revenue and ongoing reliance on related party funding, raising concerns about its ability to continue as a going concern.
Summary
- Green Planet Bioengineering Co., Ltd. operates as a public reorganized shell corporation with the goal of acquiring or merging with an existing business.
- The company did not generate any operating revenue in either 2023 or 2022.
- Total expenses were $47,670 in 2023 and $32,533 in 2022, primarily for administrative and compliance costs.
- The company's cash flow needs were met by a related party, Global Funds, as it has no active business operations.
- The company's ability to continue as a going concern is dependent on continued support from Global Funds, creating substantial doubt about its future viability.
- The company has accumulated net operating loss carryforwards of approximately $1,023,500, which may be used to reduce future taxable income through 2039, but a valuation allowance has been recorded due to uncertainty of realization.
- The company's common stock is quoted on the Over the Counter Bulletin Board under the symbol GPLB.PK, but there is no guarantee of continued quotation or liquidity.
Sentiment
Score: 2
Explanation: The document expresses significant concerns about the company's ability to continue as a going concern, its lack of revenue, and its reliance on related party funding. These factors indicate a very negative outlook from an investment perspective.
Positives
- The company has net operating loss carryforwards of approximately $1,023,500 that may be available to reduce future taxable income through 2039.
Negatives
- The company has no operating revenue.
- The company is entirely reliant on a related party for funding.
- There is substantial doubt about the company's ability to continue as a going concern.
- The company has incurred losses of $47,670 as of December 31, 2023.
- The company's stock has limited liquidity and there is no guarantee of continued quotation.
Risks
- The company's future business plans are uncertain and dependent on securing adequate financing or finding profitable business opportunities.
- The company faces significant risks and uncertainties due to its status as a public reorganized shell corporation.
- The company's ability to generate revenue is directly influenced by its ability to secure financing or find profitable business opportunities.
- The company incurs significant costs as a public company, including legal, accounting, and compliance expenses.
- The company's stock may be subject to penny stock regulations, which could restrict trading.
- The company has not paid and does not anticipate paying any dividends on its common stock.
Future Outlook
The company's future is dependent on securing adequate funding or finding profitable business opportunities, and there is no guarantee of success. The company will continue to seek funding from future investors to execute business opportunities when they arise.
Management Comments
- Management believes that the expectations reflected in the forward-looking statements are reasonable, but they do not know whether they can achieve positive future results.
- Management acknowledges that the company's ability to continue as a going concern is dependent on continued support from a related party.
Industry Context
The company operates as a shell corporation, which is a common structure for companies seeking to acquire or merge with an existing business. The lack of operating revenue and reliance on related party funding is not uncommon for such entities, but it highlights the inherent risks and uncertainties associated with this type of business model.
Comparison to Industry Standards
- It is difficult to compare Green Planet Bioengineering to industry standards due to its status as a shell corporation with no active operations.
- Unlike operating companies, Green Planet does not have revenue or typical operating expenses to benchmark against.
- The company's reliance on related party funding is a common practice for shell corporations, but it also indicates a higher level of risk compared to companies with established revenue streams.
- The company's financial situation is similar to other shell corporations that are in the process of identifying a target business for acquisition or merger.
Related Party Transactions
- The company relies on a related party, Global Funds, to advance funds for operating expenses.
- The amounts advanced are interest-free, unsecured, and repayable upon demand.
- The Chief Executive Officer, Chief Financial Officer, and Director of the Company is also a director of the related party.
Stakeholder Impact
- Shareholders face significant risk due to the company's uncertain future and lack of operating revenue.
- The company's employees, if any, are also at risk due to the company's financial instability.
- Creditors face uncertainty regarding the company's ability to repay debts.
Next Steps
- The company will continue to seek adequate funding from future investors.
- The company will continue to look for profitable business opportunities.
Key Dates
| Date | Description |
|---|---|
| October 30, 2006 | Mondo Acquisition II, Inc. was incorporated in the State of Delaware. |
| October 2, 2008 | Mondo Acquisition II, Inc. changed its name to Green Planet Bioengineering Co., Ltd. |
| October 2008 | The Company acquired Elevated Throne Overseas Ltd. |
| April 14, 2010 | The Company divested Elevated Throne to One Bio, Corp. |
| March 2012 | Global Funds Holdings Corp. became a majority stockholder of the Company. |
| June 30, 2023 | The aggregate market value of the company's common stock held by non-affiliates was $722,205. |
| December 31, 2023 | End of the fiscal year for which the 10-K report was filed. |
| March 29, 2024 | The date the 10-K report was signed and filed. |
Keywords
shell corporation, merger, acquisition, going concern, related party, operating loss, penny stock, financial statements, 10-K, GPLB.PK
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.